Prevalence and genetic diversity of HTLV-1 among blood donors in Jiroft, Iran: a comprehensive study

Fahime Edalat1, Amir Gholamzad2, Zohreh-Al-Sadat Ghoreshi3

  • 1Autophagy Research Center, Shiraz University of Medical Science, Shiraz, Iran.

Virus Genes
|April 28, 2025
PubMed

Insights

Human T-cell lymphotropic virus type 1 (HTLV-1) was detected in 1.5% of blood donors in Jiroft, Iran. This study provides crucial data on HTLV-1 prevalence and genetic diversity in an under-studied region.

Area of Science:

  • Virology
  • Epidemiology
  • Public Health

Background:

  • Human T-cell lymphotropic virus type 1 (HTLV-1) is a significant human retrovirus with a global distribution.
  • HTLV-1 infection is linked to various diseases, including adult T-cell leukemia/lymphoma and HTLV-1-associated myelopathy/tropical spastic paraparesis.
  • The prevalence and genetic diversity of HTLV-1 in Jiroft Province, southeast Iran, remain largely uncharacterized.

Purpose of the Study:

  • To determine the prevalence of HTLV-1 infection among blood donors in Jiroft Province, Iran.
  • To analyze the phylogenetic characteristics of HTLV-1 isolates from this region.
  • To assess the implications for blood safety and inform public health strategies.

Main Methods:

  • Serum samples from 405 blood donors in Jiroft Province were screened for HTLV-1 antibodies using ELISA.
  • Peripheral blood mononuclear cells (PBMCs) were analyzed by PCR targeting the Long Terminal Repeat (LTR) and TAX regions of HTLV-1.
  • Phylogenetic analysis was performed on the obtained viral sequences.

Main Results:

  • A total of 6 out of 405 blood donors (1.5%) tested positive for HTLV-1.
  • HTLV-1 prevalence was slightly higher in females (1.6%) than males (1.2%).
  • The highest prevalence (4%) was observed in the 46-64 age group. Phylogenetic analysis indicated similarities to HTLV-1 strains from Mashhad Province, with nine single-nucleotide polymorphisms (SNPs) identified in the LTR region.

Conclusions:

  • The findings establish a baseline prevalence of HTLV-1 in Jiroft Province, highlighting the need for routine screening of blood donors.
  • The genetic data contribute to understanding HTLV-1 diversity in Iran and suggest potential transmission routes.
  • Implementing effective screening measures is crucial to ensure blood transfusion safety and prevent further HTLV-1 transmission.

Related Concept Videos

Blood Transfusion and Agglutination02:45

Blood Transfusion and Agglutination

Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Rh Blood Group01:19

Rh Blood Group

The Rhesus (Rh) antigen is crucial in determining blood groups and ensuring compatibility during blood transfusions.
Blood Typing01:10

Blood Typing

Understanding an individual's blood group is a critical component of transfusion medicine. It ensures compatibility in blood transfusions, organ transplants, and even during pregnancy. Determining these blood groups involves the ABO and Rh blood typing systems, utilizing specific antigens and corresponding anti-sera to identify an individual's blood type.
Antigens are protein molecules that reside on the surface of red blood cells (RBCs). The ABO and Rh blood typing systems target antigens A,...
Blood Transfusion01:15

Blood Transfusion

Blood transfusion is a critical medical procedure that saves lives and treats various medical conditions. It involves transferring blood from a donor to a recipient. This process requires a thorough understanding of the ABO blood group system and its associated antigens and antibodies.
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...